Cowen Prime Advisors’s Ginkgo Bioworks DNA Stock Holding History

Cowen Prime Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$27.9K	Hold	375	–	–	0.01%	153
2023 Q1	$18K	Hold	375	–	–	0.01%	160
2022 Q4	$25K	Hold	375	–	–	0.01%	150
2022 Q3	$47K	Hold	375	–	–	0.03%	112
2022 Q2	$36K	Hold	375	–	–	0.02%	126
2022 Q1	$60K	Buy	+375	New	+$73K	0.03%	117

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Cowen Prime Advisors's DNA Position: Q2 2023 in Review

Cowen Prime Advisors held its Ginkgo Bioworks (DNA) position steady in Q2 2023 at 375 shares worth $27.9K. The position accounts for 0.01% of the portfolio, ranked #153.

Cowen Prime Advisors first reported a position in DNA in Q1 2022 and has held it in 6 quarters since. The position peaked at $60K in Q1 2022. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

Cowen Prime Advisors held 375 shares of Ginkgo Bioworks worth $27.9K as of Q2 2023.
Cowen Prime Advisors left its Ginkgo Bioworks share count unchanged in Q2 2023.
Ginkgo Bioworks made up 0.01% of Cowen Prime Advisors's portfolio in Q2 2023, its #153 holding.
Cowen Prime Advisors first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 6 quarters since.
Cowen Prime Advisors's Ginkgo Bioworks position peaked at $60K in Q1 2022.
315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.